Dr Mengel is Chair and Clinical Department Head for Laboratory Medicine and Pathology at the University of Alberta and with Alberta Health Services in Edmonton, Canada. As a sub-specialized Transplantation and Renal Pathologist, Dr. Mengel is engaged in various international sub-specialty societies related to nephropathology and organ transplantation: past Chair Transplant Diagnostics Community of Practice in the American Society of Transplantation; Board member International Banff Foundation for Allograft Pathology; President of the Canadian Society of Transplantation; Board member with the Renal Pathology Society.
He studied medicine at the Semmelweiss University in Budapest, Hungary before going on to specialise in pathology and further in transplantation pathology and nephropathology. Before moving to Edmonton provided transplant pathology service at the Hannover Medical School, Germany. Dr. Mengel has published widely in his field and his current work is focused on applying molecular techniques to biopsy specimens, with the aim to increase diagnostic precision in organ transplantation.
ResearchAreas of Interest:
Immunopathology with a major focus on transplantation and nephropathology.
Molecular Precision diagnostics.
Co-Principal investigator, residents involved in research
Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell L, Duong van Huyen JP, Gibson I, Mannon R, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M. The Banff 2017 Kidney Meeting Report: Revised Diagnostic Criteria for Chronic Active T Cell-Mediated Rejection, Antibody-Mediated Rejection, and Prospects for Integrative Endpoints for Next-Generation Clinical Trials. Am J Transplant. 2018, Feb;18(2):293-307
Adam BA, Smith RN, Rosales IA, Matsunami M, Afzali B, Oura T, Cosimi AB, Kawai T, Colvin RB,Mengel M. Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes. Am J Transplant. 2017 Nov;17(11):2841-2850.
Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, De Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M. The Banff 2015 Kidney meeting report: Current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant. 2017 Jan;17(1):28-41.
Afzali B, Chapman E, Racapé M, Adam B, Bruneval P, Gil F, Kim D, Hidalgo L, Campbell P, Sis B, Duong Van Huyen JP, Mengel M; Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection. Am J Transplant. 2017 Feb;17(2):496-505.